We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Midas Cap. | LSE:MDS | London | Ordinary Share | GB00B01WR582 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 20.50 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 20.50 | GBX |
Midas Capital (MDS) Share Charts1 Year Midas Capital Chart |
|
1 Month Midas Capital Chart |
Intraday Midas Capital Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 02/8/2010 | 12:32 | MIDAS Capital | 9 |
| 01/3/2007 | 08:37 | Mondas- A New Phase! | 2,286 |
| 04/5/2005 | 10:04 | Mondas- Onwards and Upwards | 891 |
| 18/11/2004 | 12:41 | MONDAS : A Tenbagger from here | 1,646 |
| 01/8/2003 | 00:06 | mondas about to rocket | 1 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 02/8/2010 12:32 by lgpixels Change of name to MAM Funds plc Midas Capital plc, the AIM quoted Fund Management company, announces that, further to the Company's General Meeting statement released yesterday, the Registrar of Companies has issued the certificate of incorporation on change of name and therefore the name of the Company has been changed to MAM Funds plc with immediate effect. Dealings under the new name will commence at 8.00 a.m. on 30 July 2010 when the Company's TIDM (ticker symbol) will change from "MDS" to "MMF"; the ISIN will remain unchanged at GB00B01WR582. |
Posted at 01/7/2010 15:23 by lgpixels Trader talkFund management company Midas Capital's executive chairman Colin Rutherford and director Martin Gray have increased their stakes in Midas, Rutherford by 350,000 shares bringing his stake in the company up to 1.8% and Gray by 257,000 bringing his holding to 2.8%. Rutherford is presently executive chairman of the board and took over as chief executive in March last year when CF Midas Balanced Growth manager Simon Edwards stepped down to concentrate on fund management. Rutherford said: "The recent share purchase is hopefully a precursor to further activity in the stock. I believe Midas has now turned the corner and despite these markets, as a focused fund management operation, we are in a good position to exploit this volatility." Gray was appointed a director of the company in mid-May and runs a raft of funds including the CF Miton Strategic and CF Miton Special Situations portfolios. |
Posted at 15/2/2007 14:05 by magpie99 Thank George.I am wary of the PE argument for 2 reasons. First it does not factor dilution. Second who is to say that the market will afford even a PE of 10 to Mondas with its track record. Its more likely give it a PE 5-10 for a couple of years and see what happens rather than be genorous. I am having a glance at a company with an innovative product just like Mondas. The company is RC group maker of software for security solutions. I find it usefull to study such a company as it gives a model for what management need to do to produce a successful company with rising share price. For instance it concentrates its efforts where it is good at, it doesnt have 3 legs to business as Mondas does. It doent seem to have this odd finance of the CULS( that have to be renegotiated again and again), and makes use of a rising share price to raise funds. The shareholders are happy and this is very good for the image of the company and must help to win new business.All in all the company has a buzz about it. Newsflow is strong and the company has connections in the right places. Mondas doen not conform to this type of model in any way, and therefore I do not believe predictions about the share price |
Posted at 03/1/2007 12:44 by magpie99 I did try to warn you all about the predictions of a 25 p share price by last Christmas and that the share price would " easily get to 25p" Even after this update from the management this share price does not even remotely seem to be able to rise to the challenge. Worryingly there is no news about orders for our CAPS flagship system, the main reason why many of us invested.No news about whether HSBC will implement the system they have bought. There is no evidence yet of any attempt by the management to get our company noticed by the press. No PR in evidence.Without a rising share price we will suffer unnecessary dilution from the BC earn out, making it harder for the share price to rise. The progress made is encouraging, but we invested in Mondas to make money and want to see a rising share price and that to me on these numbers, as I have said before looks some way off. |
Posted at 19/11/2006 12:26 by mollymolly Magpie,I agree in part with you. The numbers being met will be a major milestone, but of course we will then be looking to see what is likley to happen in 2007 and 2008. The future prospects will key to how big the share price rise is. Perhaps investment/gamble is just sematics. Investments in companies like Mondas are risky and investors(gamblers) have to weigh the possible loss against the possible gains. In looking at the downside I look at the break up value now. Perhaps Resource £5, CAPS £5, and Blue Curve say £3M. Don't forget £2M cash. These are of courses guesses, but not, I think, silly ones. Knock of the CULS and you get to double the current valuation. Anyway much more than current value. Look at the upside: 1. A steady mature Resource business generating substantial recurring revenue. 2. CAPS is the leading product in an emerging market. It is still not clear how fast this market will move, but the prospects are certainly large. The product is now well developed, robust and can be implemented quickly. A "global" rollout is underway including the US. 3. Blue Curve, again a leading product in an emerging market. Substantial new business this year including a "global" bank with again a large US part. None of these exciting possibilities are reflected in the share price at the moment. At the end of Sept T&G's analyst said that fair value was 25p. I'm sure he will upgrade that in Jan if the results appear as expected. So in the short term there is a very real prospect of doubling and if the prospects for 2007/8 can be shown to be good (the global rollouts will help here) then we should see much more. Mondas is in its best position EVER, with the share price near its lows. You can be sure that oncem Mondas' management has proved itself with the numbers for 2006 there will be some determinded promotion of the shares. I do not mind if you call it an investment or a gamble - the shares are a buy in my opinion. |
Posted at 02/11/2006 13:42 by mollymolly Rambutan,I agree with you that the share price should be higher. When Mondas acquired Blue Curve, I thought it impossible that Blue Curve could achieve the maximum earnout. Now it looks likely. I for one am happy about this. Not only have we had a huge amount of profit from Blue Curve this year, surely the base is one from which even bigger things can be looked for in 2007. I agree that it would be disappointing to pay the earnout at 17.5p share price (the company has, I think, a cash option). However, I do feel confident that the share price will be very much higher when payment is due around March next year. You comment on the size of shareholdings of the directors. Of course most comparable companies have founder directors who hold much higher stakes. We got rid of our founder! We can only guess at the financial position of the directors. It would be silly however, to assume that they have loads of cash, but do not want to invest. I presume Mr Fairman is not allowed to invest as he represents Foresight. Colin Peters has 1.6M shares so has a keen interest, and Ian Selby bought some more just over a month ago. Magpie, I am sure that there is a solid level of support for the directors and although the share price is still low that does not mean that the company could be bought at anything like the current level. Most holders are long term holders who have invested in the hope and expectation that the Company's products will take off. We are very unlikely to agree to sell just when things are coming good. |
Posted at 24/10/2006 20:42 by mollymolly Magpie,You have not mentioned any problems at all that could conceivably cause the issue of more shares in order for Mondas "to buy its way out of trouble". The major problem that Mondas has is that its shares are poorly rated. The evidence is that all parts of the business are performing well. Trading profitably and therefore cash generative. There will not be a cash call. You are right about the £1m raised; add to that the £534k at the ½ year and cash generated in the second half to get my guesstimate of £2m. The other causes of share issue would be another acquisition and the payment of the earn out to Blue Curve in March 2007. Neither of these eventualities could be called "buying out ...of trouble" The two acquisitions made so far have been very successful. As far as I am aware there is no likelihood of making further acquisitions at this sort of share price. I agree with you that "critical mass" is significant, but I am sure that the directors would take the view that any future deals will have to be at a much higher share price. Now that it is clear that the business is running well in its three market areas, it makes more sense to allow organic growth to prove itself before buying more companies. You are right about the likely issue of shares to Blue Curve at the completion of the earn out. The T&G forecast assumes that Blue Curve would perform at the minimum level and so no additional payment would be made. My guess is that 50-70k is included in the T&G number for Blue Curve. If they are to make the full earn out, I think that there will be at least an additional profit of 500k coming from Blue Curve alone. At the half year we had a provision for additional payment, clearly some substantial earn out payment will be made (in cash or shares) THIS HAS BEEN A GOOD BUY. Most of us bought Mondas shares because we got excited about the CAPS prospects. The CAPS market really is still there. Very very slow progress has been made over the years. Most institutions are still processing Corporate Actions manually and it is obvious that this area will be automated over the next few years. Mondas does have the world-leading product and several other companies are trying unsuccessfully (so far) to compete with Mondas. There is no short-term prospect of your 2 or three global rollouts and nor are any needed to make the 2006 and 2007 forecasts. If/when? Mondas does achieve 2/3 global rollouts (value say £8-10m) Mondas will be highly values indeed. I certainly agree that CAPS has been frustratingly slow, there has been a protracted and painful period of development. I believe that we can be confident that we now have a robust and mature product. Panmure and Finn were installed smoothly in 3 months, and we would not be getting the global rollout if there were still software glitches or deficiencies in the functionality. You ask will the performance of CAPS justify the investment? We will have to see over the next year or two. Certainly, so far, it has cost more than it contributed. This year clearly we have turned into profit on the CAPS business. We do need more CAPS deals, we have been told that prospects are better than ever, but we all know how frustratingly slow it can be to land new business. Mondas has landed more CAPS business this year than in any other and the global CAPS rollout, especially including the US, is a very exciting development. Shareholders can be excused for scepticism, as we have seen many false dawns over the years, but we are in pole position to take advantage of the emerging CAPS market. I agree with the comments from you and spurious about PR. The share price is just where it was after the following: . Charles Stanley Contract . MDM Bank in Russia . Decent Interim results with bullish outlook statement . T&G BUY note with 25p target . Ian Selby buys shares. All of that and the price falls!!! What nonsense. I know that the directors will be looking hard at that. The directors must be doing something wrong for the share price not to rise significantly on 5 decent bits of news. Certainly, I have to accept that my expectations about the share price have been wrong, I have held many Mondas shares for years now and have an average buying price of just under 30p. I can assure you I am most unhappy about the performance of my Mondas investment. It would make an already long post a monster to go into the history. Anyway it is the future not the past we should look to. Over the years I have got to know Mondas well and I am sure that we are in the best position EVER. Of course we want more. We want CAPS, BC and Resource orders, but I believe we really have turned the corner to consistent profits growth. I believe that the forecasts are reasonable with a much better chance of being beaten than missed. |
Posted at 31/8/2006 12:30 by magpie99 All " knowledgeable" shareholders have been saying this for many years, but have proved themselves delinquent in their forecasts.The Mondas management has not been able convert improved financial performance, into share price gain. Any improved share price will be used to more raise funds and issue more shares, keeping a lid on the share price, as selling software is an expensive businees as we can see. I will not comment on what I think the share price could be as I see this as irresponsible. |
Posted at 11/8/2006 10:41 by spurious Hi amt My understanding is that the main body of re-negotiated culs are not due for redemption until oct 2011. The share price is irrelevant and as george pointed out why would the holders give up an annual return at twice the current bank rate.It would also not surprise me that certain guarantees would be given by the respective parties so that the benefit of certainty would be underwritten. Perhaps your post was referring to the additional £1m placing where if the share price reaches £1 for 30 consecutive days then the culs have to be redeemed. That would be a situation we would all be delighted with Another thought I am sure we would all ,including the directors, be extremely dissappointed if the share price was not in the 40p range within 12 months and substantially higher over the next few years. What is to prevent a further re-negotiation of culs from a position of strength in 2/3 years as I would feel the culs holders could still be willing to enjoy the attractive divi and if we had a share price of say 65p in 2/3years then a re-negotiation for a futher 5 years at say a price of say 40p would represent an attractive proposition (a near 25% discount to the then strengthened Mondas share price with a guaranteed annual divi of 100% above the equiv bank rate} with an 80% improvement from the current proposal to shareholders. My point is the dilution only occurs when the shares are redeemed and I agree with Rambutan that I believe when the market recognises what is being achieved then the share price will move into line. In 2/3 years Mondas will be an entirely different beast with at least one new acquisition. I hope we will see a growing presence in America and the far east led by Blue Curve initially but with Caps feeding off the cross-selling opportunities world wide. I hope to see Caps with at least 2 global orders from major financial institutions with several broker deals and established as a genuine world leader. I hope to see Resource double its profit within the next 2 years . I hope the coming 12 months results will deliver £1million profit and when as I believe all of this does become reality then I hope the share price will reflect real value I genuinely believe that we could see the additional culs placing redeemed within the allotted timescale due to a higher share price ie in excess of £1 within the next 5 years. I am really trying to point out that Mondas will have a good degree of flexibility by this latest move so dilution may well not be anything like as drastic as initially thought ,if at all( should re-negotiation occur) These, some may say, may be the ramblings of someone who has just staggerred off the park bench and set his plastic mac on fire downing his 20th meth flambee in a row.I would like to think that they were the honest and considered remarks of a fellow shareholder. We will see a substantial improvement in the next few months and good ol Mari would seem to agree Regards to all SP |
Posted at 04/8/2006 15:33 by spurious Hi all Just back from holiday and have beem catching up with the news. Agree with all that has been said including the good bits....I would just add my congrats to Jarlath and rest of team mondas and suggest that if as I strongly suspect Blue Curves client is new to Mondas then another opportunity to introduce Caps on a global scale must remain a distinct possibility. Alas some things never seem to change... Mondas continue to go from strength to strength yet we see a share price that reflects neither confidence nor in my oppinion value. I and many others on this board have put our money where our mouths are and consistently backed the Co with our hard earned cash. Rumours of a persistent seller have perhaps drained the share price. What an opportunity for the board, old and new, to go out and confirm our belief that Mondas represents a fantastic buying opportunity by purchasing a significant amount of equity and also taking out any overhang that exists. In my oppinion significant director buying often transforms the shareprice where a company has had a dissappointing past but is now undergoing fundamental change and enjoying real success,unnoticed by the wider market. Indigovision was a perfect example of this. Were those that are closest to the company, by their actions, to show that they believed that Mondas was fundamentaly undervalued then I believe the market would quickly rerate the share price and perhaps allow the company more flexibility to build on its successes from a strengthened share price and with consequently less dilution to its shareholders. I am sure Jarlath and team Mondas are equally frustrated with the current situation. Regards to all SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
